Myocardial kinetics of carbon-11-meta-hydroxyephedrine: Retention mechanisms and effects of norepinephrine

Timothy R DeGrado, G. D. Hutchins, S. A. Toorongian, D. M. Wieland, M. Schwaiger

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Carbon-11-labeled meta-hydroxyephedrine (HED, N-methyl-metaraminol) is a catecholamine analog developed for the PET imaging of sympathetic nerve terminals of the heart. The retention mechanisms of this tracer and interactions with norepinephrine were investigated in isolated working rat hearts. Externally monitored time-activity curves showed a strong uptake process in control hearts (K1 = 2.66 ± 0.39 ml/g/min) and relatively slow monoexponential clearance rates (k2 = 0.011 ± 0.003 min-1). Comparative studies with the neuronal uptake inhibitor desipramine indicated little extraneuronal distribution and a strong dependence of clearance rate on neuronal reuptake of tracer. Norepinephrine (≤ 10 nM) increased HED clearance rate without affecting initial uptake rates. This effect may be related to competitive inhibition of neuronal reuptake and/or accelerated neuronal release of HED. These results indicate that the uptake and retention of HED by the myocardium is highly specific to sympathetic nerve terminals. However, its retention in the myocardium is not directly related to neuronal processing of catecholamines (i.e., metabolism and vesicular turnover). Thus, important differences may exist in the physiologic information indicated by retention measurements of HED and radiolabeled catecholamines. The finding of increased clearance rates with NE in the perfusion medium recommends the consideration of potential effects of circulating and endogenous catecholamines on PET measurements of myocardial retention of HED, especially in subjects with elevated plasma catecholamines or high sympathetic tone.

Original languageEnglish (US)
Pages (from-to)1287-1293
Number of pages7
JournalJournal of Nuclear Medicine
Volume34
Issue number8
StatePublished - 1993
Externally publishedYes

Fingerprint

Catecholamines
Norepinephrine
Carbon
Myocardium
Metaraminol
Desipramine
Perfusion
3-hydroxyephedrine

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

DeGrado, T. R., Hutchins, G. D., Toorongian, S. A., Wieland, D. M., & Schwaiger, M. (1993). Myocardial kinetics of carbon-11-meta-hydroxyephedrine: Retention mechanisms and effects of norepinephrine. Journal of Nuclear Medicine, 34(8), 1287-1293.

Myocardial kinetics of carbon-11-meta-hydroxyephedrine : Retention mechanisms and effects of norepinephrine. / DeGrado, Timothy R; Hutchins, G. D.; Toorongian, S. A.; Wieland, D. M.; Schwaiger, M.

In: Journal of Nuclear Medicine, Vol. 34, No. 8, 1993, p. 1287-1293.

Research output: Contribution to journalArticle

DeGrado, TR, Hutchins, GD, Toorongian, SA, Wieland, DM & Schwaiger, M 1993, 'Myocardial kinetics of carbon-11-meta-hydroxyephedrine: Retention mechanisms and effects of norepinephrine', Journal of Nuclear Medicine, vol. 34, no. 8, pp. 1287-1293.
DeGrado, Timothy R ; Hutchins, G. D. ; Toorongian, S. A. ; Wieland, D. M. ; Schwaiger, M. / Myocardial kinetics of carbon-11-meta-hydroxyephedrine : Retention mechanisms and effects of norepinephrine. In: Journal of Nuclear Medicine. 1993 ; Vol. 34, No. 8. pp. 1287-1293.
@article{b60790a334b84d0f9cc965f7263540be,
title = "Myocardial kinetics of carbon-11-meta-hydroxyephedrine: Retention mechanisms and effects of norepinephrine",
abstract = "Carbon-11-labeled meta-hydroxyephedrine (HED, N-methyl-metaraminol) is a catecholamine analog developed for the PET imaging of sympathetic nerve terminals of the heart. The retention mechanisms of this tracer and interactions with norepinephrine were investigated in isolated working rat hearts. Externally monitored time-activity curves showed a strong uptake process in control hearts (K1 = 2.66 ± 0.39 ml/g/min) and relatively slow monoexponential clearance rates (k2 = 0.011 ± 0.003 min-1). Comparative studies with the neuronal uptake inhibitor desipramine indicated little extraneuronal distribution and a strong dependence of clearance rate on neuronal reuptake of tracer. Norepinephrine (≤ 10 nM) increased HED clearance rate without affecting initial uptake rates. This effect may be related to competitive inhibition of neuronal reuptake and/or accelerated neuronal release of HED. These results indicate that the uptake and retention of HED by the myocardium is highly specific to sympathetic nerve terminals. However, its retention in the myocardium is not directly related to neuronal processing of catecholamines (i.e., metabolism and vesicular turnover). Thus, important differences may exist in the physiologic information indicated by retention measurements of HED and radiolabeled catecholamines. The finding of increased clearance rates with NE in the perfusion medium recommends the consideration of potential effects of circulating and endogenous catecholamines on PET measurements of myocardial retention of HED, especially in subjects with elevated plasma catecholamines or high sympathetic tone.",
author = "DeGrado, {Timothy R} and Hutchins, {G. D.} and Toorongian, {S. A.} and Wieland, {D. M.} and M. Schwaiger",
year = "1993",
language = "English (US)",
volume = "34",
pages = "1287--1293",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "8",

}

TY - JOUR

T1 - Myocardial kinetics of carbon-11-meta-hydroxyephedrine

T2 - Retention mechanisms and effects of norepinephrine

AU - DeGrado, Timothy R

AU - Hutchins, G. D.

AU - Toorongian, S. A.

AU - Wieland, D. M.

AU - Schwaiger, M.

PY - 1993

Y1 - 1993

N2 - Carbon-11-labeled meta-hydroxyephedrine (HED, N-methyl-metaraminol) is a catecholamine analog developed for the PET imaging of sympathetic nerve terminals of the heart. The retention mechanisms of this tracer and interactions with norepinephrine were investigated in isolated working rat hearts. Externally monitored time-activity curves showed a strong uptake process in control hearts (K1 = 2.66 ± 0.39 ml/g/min) and relatively slow monoexponential clearance rates (k2 = 0.011 ± 0.003 min-1). Comparative studies with the neuronal uptake inhibitor desipramine indicated little extraneuronal distribution and a strong dependence of clearance rate on neuronal reuptake of tracer. Norepinephrine (≤ 10 nM) increased HED clearance rate without affecting initial uptake rates. This effect may be related to competitive inhibition of neuronal reuptake and/or accelerated neuronal release of HED. These results indicate that the uptake and retention of HED by the myocardium is highly specific to sympathetic nerve terminals. However, its retention in the myocardium is not directly related to neuronal processing of catecholamines (i.e., metabolism and vesicular turnover). Thus, important differences may exist in the physiologic information indicated by retention measurements of HED and radiolabeled catecholamines. The finding of increased clearance rates with NE in the perfusion medium recommends the consideration of potential effects of circulating and endogenous catecholamines on PET measurements of myocardial retention of HED, especially in subjects with elevated plasma catecholamines or high sympathetic tone.

AB - Carbon-11-labeled meta-hydroxyephedrine (HED, N-methyl-metaraminol) is a catecholamine analog developed for the PET imaging of sympathetic nerve terminals of the heart. The retention mechanisms of this tracer and interactions with norepinephrine were investigated in isolated working rat hearts. Externally monitored time-activity curves showed a strong uptake process in control hearts (K1 = 2.66 ± 0.39 ml/g/min) and relatively slow monoexponential clearance rates (k2 = 0.011 ± 0.003 min-1). Comparative studies with the neuronal uptake inhibitor desipramine indicated little extraneuronal distribution and a strong dependence of clearance rate on neuronal reuptake of tracer. Norepinephrine (≤ 10 nM) increased HED clearance rate without affecting initial uptake rates. This effect may be related to competitive inhibition of neuronal reuptake and/or accelerated neuronal release of HED. These results indicate that the uptake and retention of HED by the myocardium is highly specific to sympathetic nerve terminals. However, its retention in the myocardium is not directly related to neuronal processing of catecholamines (i.e., metabolism and vesicular turnover). Thus, important differences may exist in the physiologic information indicated by retention measurements of HED and radiolabeled catecholamines. The finding of increased clearance rates with NE in the perfusion medium recommends the consideration of potential effects of circulating and endogenous catecholamines on PET measurements of myocardial retention of HED, especially in subjects with elevated plasma catecholamines or high sympathetic tone.

UR - http://www.scopus.com/inward/record.url?scp=0027198327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027198327&partnerID=8YFLogxK

M3 - Article

C2 - 8326386

AN - SCOPUS:0027198327

VL - 34

SP - 1287

EP - 1293

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 8

ER -